EMM Disclosure
24 February 2003 - 10:31PM
UK Regulatory
RNS Number:8618H
J.P. Morgan Securities Ld(EMM)
24 February 2003
FORM 38.5 (SUMMARY)
Lodge with Company Announcements Office and the Panel. Use a separate form for
each class of securities in which dealings have been made.
CONNECTED EXEMPT MARKET-MAKERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS
Name of EMM ...... J.P. Morgan Securities Ltd .................................
....................................
Date of disclosure ...24th February 2003............... ........................
.................................
Contact name ............Sara Moth.................. ...........................
.............................
Telephone number ............020 7325 5808... .................................
..........................
Please see attached disclosure of dealings under Rule 38.5 in the securities of
the following companies:
Cambridge Antibody Technology Group plc
AMENDMENT
If the attached Rule 38.5 disclosure is to amend a previous disclosure, please
state which element (s) of previous disclosure was incorrect:
In the case of option business or dealings in derivatives full details should be
given on a separate sheet so that the nature of the dealings can be fully
understood. For options this should include the number of securities under
option, the exercise period (or in the case of exercise, the exercise date), the
exercise price and any option money paid or received. For derivatives this
should include, at least, the number of reference securities to which they
relate (when relevant), the maturity date (or if applicable the closing out
date) and the reference price.
For full details of disclosure requirements see Rules 8 and 38 of the code. If
in doubt contact the Monitoring Section of the Panel,
Tel. No: 020 7638 0129
CONNECTED EXEMPT MARKET-MAKERS;
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS
Dealing in .....................Cambridge Antibody Technology Group plc...
.......(name of company)
Class of security .......................................Ordinary Shares......
..................................
Date of disclosure .................................24th February 2003.........
.................................
Date of dealing .......................................21st February 2003......
.................................
Name of EMM ....................................J.P. Morgan Securities Ltd......
...........................
Name of offeree/offeror with whom connected .........Cambridge Antibody
Technology Group plc .........
Total number of securities purchased 34,682
Highest price paid* 4.30 GBP
Lowest price paid* 4.30 GBP
Total number of securities sold 34,682
Highest price received* 4.32 GBP
Lowest price received* 4.29 GBP
* Currency must be stated
This information is provided by RNS
The company news service from the London Stock Exchange
END
EMMSEMFFLSDSEEE